Title | Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications [electronic resource] / edited by J.-C. Fruchart, A. M. Gotto, R. Paoletti, B. Staels, A. L. Catapano |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 2002 |
Connect to | http://dx.doi.org/10.1007/978-1-4615-1171-7 |
Descript | XVI, 172 p. online resource |
1. Peroxisome Proliferator Activated Receptor Alpha Coordinates Intermediary Metabolism During Fasting -- 2. Design, Structure, and Function of Novel PPAR Ligands -- 3. Functions of PPAR Gamma in Macrophages and Atherosclerosis -- 4. PPARs and Atherogenesis: Mediators or Modulators of the Inflammatory Response in the Vessel Wall? -- 5. Role of PPARs in Inflammation, Atherosclerosis, and Thrombosis -- 6. Effects of Thiazolidinediones on Vascular Reactivity and Endothelial Dysfunction -- 7. Activation of Human PPAR Subtypes by Pioglitazone -- 8. PPAR? Mechanism of Action Studies -- 9. The Role of PPAR? in Fatty Acid Metabolism and Hepatocarcinogenesis: Studies with PPAR?-Null Mice -- 10. PPAR?, Lipoprotein Metabolism, Metabolic Disease, and Atherosclerosis -- 11. PPAR? and Atherosclerosis -- 12. Regulation of CD36 by PPAR?: Pro- or Anti-atherogenic? -- 13. Anti-inflammatory Properties of High Density Lipoproteins -- 14. The Low-HDL Syndrome: Epidemiology and Pathophysiology -- 15. Diabetes: A Growing CHD Epidemic -- 16. Influence of PPARs on Muscle Lipid Metabolism and Insulin Resistance -- 17. PPAR? in Adipogenesis and Insulin Resistance -- 18. Pharmacology of a Selective Peroxisome Proliferator-Activated Receptor ? Agonist, GW501516, in Obese Dyslipidemic Primates -- 19. PPAR?: A Regulator of Growth and Differentiation -- 20. Peroxisome Proliferator Activator Receptor Gamma Agonists Inhibit the Development of Atherosclerosis in Low Density Lipoprotein Receptor-Deficient Male Mice -- 21. Are Thiazolidinediones Superior to Standard Therapy in the Treatment of Type 2 Diabetes? -- 22. PPAR? Ligands and Intestinal Inflammation -- 23. Inflammatory Mechanisms in Alzheimerโs Disease: ?-Amyloid-Stimulated Proinflammatory Responses Are Blocked by PPAR? Agonists